Enhancement the Dissolution Rate and Solubility of Poorly Soluble Drugs: Review

Abstract:

The use of reduction and nucleation technologies in nanosize active pharmaceutical ingredient (API) is as an enabling to bring improved drug products to the marketplace demand as well as for improved drug delivery. nanoPharmaceutical field represents a hopeful set of pharmaceutical materials offering the prospect of better alternatives to optimize drug physical properties and biopharmaceutical issues such as solubility, stability and bioavailability in pharmaceutical development without changing the chemical composition of the API, thereby, giving new patentable solid forms. With physically improved solid API may impact the the pharmaceutical intellectual property landscape. Nanoparticle formation is achievable in many ways, although primarily through particle reduction or through manipulation of the nucleation mechanism. Keywords: active pharmaceutical ingredient; drug delivery; ultra rapid freezing.

• Periodical: Advanced Materials Research (Volume 701)
• Pages: 234-238
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.701.234
• Online since: May 2013
• Authors: Mubarak Abdullah Saleh, Salam A. Mohammed, Ezzat C Abdullah, Laith A. Hashim
• Keywords: Active Pharmaceutical Ingredient, Drug Delivery, Ultra Rapid Freezing

References

[1] Laith A. H., Ezzat C. A., Abdul Aziz A. R., and Salam A. M., Isoniazid Active Pharmaceutical Ingredient in Nano Size Using Ultra Rapid Freezing. Nanosci. Nanotechnol. Lett., Vol. 5 (xx): 1-7 (2013)

DOI: 10.1166/nnl.2013.1596

[2] Chaturvedi, A.K., and Amita Vermai. "Solubility Enhancement of Poorly Water Soluble Drugs by Solid Dispersion. International Journal of Pharmaceutical Science and Research 3 (1): 26-34 (2011).

[3] Yohei Kawabata, Koichi Wada, Manabu Nakatani, Shizuo Yamada, and Satomi Onoue. "Formulation Design for Poorly Water-soluble Drugs Based on Biopharmaceutics Classification System: Basic Approaches and Practical Applications." Internation Journal of Pharmaceutical, 25;420 (1):1-10 (2011).

DOI: 10.1016/j.ijpharm.2011.08.032

[4] Merisko-Liversidge, Elaine M., and Gary G. Liversidge. Drug Nanoparticles: Formulating Poorly Water-soluble Compounds. Toxicol Pathol 36 (1): 43-48 (2008).

DOI: 10.1177/0192623307310946

[5] Sahoo S.K., Parveen S., MS, and Panda J.J.. The Present and Future of Nanotechnology in Human Health Care. Nanomedicine: 3 (1): 20-31 (2007).

DOI: 10.1016/j.nano.2006.11.008

[6] Najmuddin M., Tousif Khan, Mohsin AA, S. Shelar, and Vishal Patel. Enhancement of Dissolution Rate of Ketoconazole by Solid Dispersion. International Journal of Pharmacy and Pharmaceutical Science, 3 (2): 132-136 (2010).

[7] Dhirendra K,, Lewis S, Udupa N, and Atin K. Solid Dispersions: A Review. Pak. J. Pharm. Sci, 22 (2): 234-246 (2009).

[8] Albert H. L. Chow, Henry H. Y. T, Pratibhash Chattopadhyay, and Boris Y. Shekunov. Particle Engineering for Pulmonary Drug Delivery. Pharm Res 24 (3): 411-38 (2007).

DOI: 10.1007/s11095-006-9174-3

[9] Muller R. H., Jacobs C., and Kayser O., Adv. Drug Deliv. Rev. 47, 3 (2001).